Literature DB >> 1695639

Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid.

H Link1, S Baig, O Olsson, Y P Jiang, B Höjeberg, T Olsson.   

Abstract

Antibodies to myelin components, such as myelin basic protein (MBP), may play a role in pathogenesis of multiple sclerosis (MS) but results from determinations of anti-MBP antibodies are inconsistent. Enumeration of cells secreting antibodies represents a new approach to evaluate a specific antibody response regarding extent and localization, and reduces effects of e.g. antibody binding to target. Anti-MBP IgG antibody secreting cells were present in MS patients' cerebrospinal fluid (CSF) at a mean value of 1 per 833 cells, and they amounted to a mean value of about 2454 in the whole CSF compartment. Similar numbers were encountered in patients with other inflammatory neurological diseases (OIND). During follow-up, anti-MBP IgG antibody secreting cells persisted regarding frequency and numbers in MS, but decreased in OIND. Such cells were rarely detected in patients with tension headache. No correlations to clinical exacerbation of MS, disability or duration were discernable. In blood from MS and OIND patients, anti-MBP IgG antibody secreting cells were detected infrequently and at low numbers. The anti-MBP antibody response is strongly restricted to the IgG isotype. The anti-MBP IgG antibody response which is persistent and compartmentalized to the diseased organ, may be important for the development of MS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695639     DOI: 10.1016/0165-5728(90)90017-h

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  A role for complement in phagocytosis of myelin.

Authors:  B A DeJong; M E Smith
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Antibodies in multiple sclerosis oligoclonal bands target debris.

Authors:  Ryan C Winger; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-28       Impact factor: 11.205

3.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

Authors:  K Akassoglou; J Bauer; G Kassiotis; M Pasparakis; H Lassmann; G Kollias; L Probert
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.

Authors:  Jenna L Bowen; Julie K Olson
Journal:  Viral Immunol       Date:  2013-07-05       Impact factor: 2.257

6.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Hyperserotoninemia and antiserotonin antibodies in autism and other disorders.

Authors:  A Yuwiler; J C Shih; C H Chen; E R Ritvo; G Hanna; G W Ellison; B H King
Journal:  J Autism Dev Disord       Date:  1992-03

8.  Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia.

Authors:  Irene Meester; Gerardo Francisco Rivera-Silva; Francisco González-Salazar
Journal:  Front Neurosci       Date:  2020-01-17       Impact factor: 4.677

9.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.